Lottery Email Address IGT pens extension with Kansas Lottery AddThis Sharing ButtonsShare to LinkedInLinkedInShare to FacebookFacebookShare to TwitterTwitter 22nd March 2019 | By contenteditor Topics: Lottery Tech & innovation Subscribe to the iGaming newsletter International Game Technology (IGT) has signed a three-year extension to its deal with the Kansas Lottery, continuing the partnership until at least 2022.Under the renewed agreement, IGT will continue to provide the Lottery with its INTELLIGEN central computer system and services to monitor electronic gaming machines throughout the state.IGT, which brokered the deal via its IGT Global Solutions Corporation subsidiary, has said the extended agreement will come into effect from December 15, 2019.“IGT’s INTELLIGEN system has helped the Kansas Lottery meet the objectives of operating our electronic gaming machines with the highest standards of integrity and security to benefit the state for the last 10 years,” Kansas Lottery acting executive director Stephen Durrell said.“We look forward to continuing our relationship over the next few years.”Jay Gendron, chief operating officer for North American lottery at IGT, added: “IGT and the Kansas Lottery have built a strong partnership since this contract began more than 10 years ago, and we’re pleased to be furthering this relationship by continuing to provide our advanced system to the nearly 5,000 electronic gaming machines in the state.”IGT also recently extended its deal with the DC Lottery in Washington DC. Also in North America, IGT earlier this month signed an extension to its partnership with Canadian provincial lottery organisation Loto-Québec. Regions: US Kansas International Game Technology (IGT) has signed a three-year extension to its deal with the Kansas Lottery, continuing the partnership until at least 2022.
FBC Holdings Limited (FBC.zw) listed on the Zimbabwe Stock Exchange under the Banking sector has released it’s 2011 abridged results.For more information about FBC Holdings Limited (FBC.zw) reports, abridged reports, interim earnings results and earnings presentations, visit the FBC Holdings Limited (FBC.zw) company page on AfricanFinancials.Document: FBC Holdings Limited (FBC.zw) 2011 abridged results.Company ProfileFBC Holdings Limited (FBC Bank) is a financial institution in Zimbabwe providing financial products and solutions for retail, commercial and corporate banking; with a range of products and services extending from savings deposit accounts and micro-lending in the informal market to foreign market investment, mortgage financing, micro-lending, re-insurance, short-term insurance and stock-brokering services. Its re-insurance division underwrites classes of insurance for fire, engineering, motoring, marine and miscellaneous incidences. FBC Bank is a wholly-owned subsidiary of First Banking Corporation Holdings Limited which is a publicly-traded financial services company in Zimbabwe. FBC Holdings Limited is listed on the Zimbabwe Stock Exchange
There’s a perception that the US has all the high-growth technology stocks in the US and that UK tech shares tend to be bought by overseas companies. For example, SoftBank bought ARM Holdings back in 2016. And now Nvidia is taking it over. However, the UK does have listed technology shares. One of these shares is artificial intelligence company RenalytixAI (LSE: RENX). The share price has leapt recently, which raises the question: could the shares rocket further or are they now too expensive?5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…What does the company do?First of all, let’s look at what it does. RenalytixAI provides artificial intelligence-based diagnostics for kidney disease through its KidneyIntelX platform. The algorithm combines data in order to provide a patient risk score which then helps doctors treat patients better.It has a niche which is actually quite a large addressable market, especially in the US. Chronic kidney conditions there affect 15% of adults or 37m people. This costs Medicare over $120bn per year.Obviously, the problem stretches beyond the US and is global, so there’s a huge potential market for an AI diagnostics tool to help doctors.Why has the share price risen and what’s the opportunity for future growth?I think it’s the potential for the company to get approval from the US Food and Drug Administration (FDA) that is boosting the shares. Approvals to sell its tests at $950 a time to healthcare facilities across the US could be transformative for the company, which makes no revenue for now. An update is expected within the coming months, hence the share price leap. Beyond the immediate prospect of the FDA announcement, the AI company has partnerships with AstraZeneca and Mount Sinai in the US. The latter is a joint venture for a Covid-19 test, which could be rolled out globally. That could be another source of revenue in the future. Longer term, if RenalytixAI can roll out successfully across the US there could be huge opportunities in other international markets. Also in the future, there will almost certainly be more chances to apply artificial intelligence to other healthcare problems. Once the technology is accepted and trusted there will be a lot of other opportunities to cut healthcare costs and improve outcomes for patients. Spending on solutions at that point should accelerate quickly. What will I do with this UK tech share?For now when it comes to the share price, I’ll wait and see. When a share price rises this much in such a short space of time there’s certainly more risk. I worry I may be late to the party and arrive just as the share price starts to revert back towards more usual levels. I’ll add the UK tech share to my watchlist and see what happens next. It’s possible, of course, the FDA might not rule in favour of RenalytixAI, or other operational hurdles may appear. That’s why I remain quietly optimistic, but also cautious. Andy Ross owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Image source: Getty Images. Enter Your Email Address I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Our 6 ‘Best Buys Now’ Shares Get the full details on this £5 stock now – while your report is free. Andy Ross | Saturday, 30th January, 2021 | More on: RENX Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. The price of this UK tech share is up over 80% in just the last month. Would I buy? Are you on the lookout for UK growth stocks?If so, get this FREE no-strings report now.While it’s available: you’ll discover what we think is a top growth stock for the decade ahead.And the performance of this company really is stunning.In 2019, it returned £150million to shareholders through buybacks and dividends.We believe its financial position is about as solid as anything we’ve seen.Since 2016, annual revenues increased 31%In March 2020, one of its senior directors LOADED UP on 25,000 shares – a position worth £90,259Operating cash flow is up 47%. (Even its operating margins are rising every year!)Quite simply, we believe it’s a fantastic Foolish growth pick.What’s more, it deserves your attention today.So please don’t wait another moment. Simply click below to discover how you can take advantage of this. FREE REPORT: Why this £5 stock could be set to surge See all posts by Andy Ross